( 2058 results )
Competition Commission of India

CCI: consents Abbott Laboratories - St. Jude Medical, Inc. proposed combination post modification in merger

  • Citation Number : LSI-1385-CCI-2016-(NDEL)
Competition Commission of India

CCI: approves 25% stake acquisition by Mitsui in GA Holdco and ultimate acquisition of 12.52% in GA

  • Citation Number : LSI-1384-CCI-2016-(NDEL)
Competition Commission of India

CCI: Approves Bharatiya Mahila Bank Ltd. – SBI amalgamation sans appreciable adverse effect

  • Citation Number : LSI-1383-CCI-2016-(NDEL)
Competition Commission of India

CCI: dismisses Informant’s complaint against Jaguar Land Rover India Ltd. as Companies not dominant in the relevant market

  • Citation Number : LSI-1382-CCI-2017-(NDEL)
Competition Appellate Tribunal

COMPAT: Dismisses ‘defective’ appeal for want of correction despite intimation more than year ago

  • Citation Number : LSI-1367-COMPAT-2016-(NDEL)
Competition Commission of India

CCI: Nods Gland Pharma Ltd acquisition by Fosun Pharma Industrial PTE Ltd absent adverse effect in relevant market

  • Citation Number : LSI-1366-CCI-2016-(NDEL)
Competition Commission of India

CCI: Dismisses case against subsidiaries of Daimler AG; Finds no violation of Sections 3 & 4

  • Citation Number : LSI-1365-CCI-2017-(NDEL)
Competition Commission of India

CCI: Approves acquisition of Sun Pharma’s brands & products by RPG Life Science; Impact on Indian markets insignificant

  • Citation Number : LSI-1364-CCI-2016-(NDEL)
Competition Commission of India

CCI: Approves Guardian – KII merger absent change in competition dynamics from joint venture to sole control

  • Citation Number : LSI-1363-CCI-2017-(NDEL)
Competition Appellate Tribunal

COMPAT: Dismisses UTV’s impleadment & order rectification application on technical grounds

  • Citation Number : LSI-1355-COMPAT-2017-(NDEL)
Competition Commission of India

CCI: Approves Ashok Leyland – Hinduja Foundries merger for revival of latter, absent ‘appreciable adverse effect’ on competition

  • Citation Number : LSI-1353-CCI-2016-(NDEL)
Competition Commission of India

CCI: Personal money dispute cannot raise any competition concern under Sec 3, dismisses complaint

  • Citation Number : LSI-1352-CCI-2016-(NDEL)
Competition Commission of India

CCI: approves acquisition of Emerson Electric Co. by Nidec Corporation, finds no adverse effect and competitive concern

  • Citation Number : LSI-1351-CCI-2016-(NDEL)
Competition Commission of India

CCI: approves JV between Allegheny Technologies and General Electric Company

  • Citation Number : LSI-1352-CCI-2016-(NDEL)
Competition Commission of India

CCI: Gives nod to acquisition of TVS logistical Services by CDPQ Asia subject to modifications

  • Citation Number : LSI-1352-CCI-2016(NDEL)
Competition Commission of India

CCI: Approves ICU’s acquisition of Pfizer & Hospira Infusions Systems, states no appreciable adverse effect

  • Citation Number : LSI-1348-CCI-2017-(NDEL)
Competition Commission of India

CCI: Approves Madison’s 2% stake buy in Micromax as no horizontal overlap

  • Citation Number : LSI-1347-CCI-2016-(NDEL)
Competition Commission of India

CCI: Delayed plots allotment, price escalations, no possession & lopsided penalty conditions, prima facie ‘dominance abuse’ by DDA

  • Citation Number : LSI-1343-CCI-2017-(NDEL)
Competition Commission of India

CCI: Approves Aspen’s proposition to acquire commercialization rights of Glaxo’s injectable anti-coagulants

  • Citation Number : LSI-1342-CCI-2016-(NDEL)
Competition Commission of India

CCI: Imposes penalties on 3 firms for ‘collusive bidding’ for supply of fans to Indian Railways

  • Citation Number : LSI-1341-CCI-2017-(NDEL)